Dudediligence.

Zenas BioPharma, Inc

ZBIONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$5.0MDec ’24$10.0MMar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25$1.0MJun ’26
Net income, by quarter
−$38.6MSep ’24−$52.6MDec ’24−$33.6MMar ’25−$52.2MJun ’25−$51.5MSep ’25−$240.4MDec ’25−$81.0MMar ’26−$111.5MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$50.0M$5.0M$10.0M
Operating incomenone on file−$37.1M−$163.9M−$383.1M
Net incomenone on file−$37.1M−$157.0M−$377.7M
Operating cash flownone on file−$30.5M−$119.7M−$172.3M
Free cash flownone on file−$30.5M−$119.8M−$172.4M
Cash$67.3M$56.9M$319.7M$110.6M
Debtnone on filenone on filenone on file$78.6M
Shares outstandingnone on file1.6M41.8M54.5M